A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems

Recruiting

Phase 1

BI 3000202A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems

Sponsor:

Boehringer Ingelheim

Code:

NCT07486102

Conditions

Healthy

Hepatic Impairment

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

BI 3000202

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-20. This information was provided to ClinicalTrials.gov by Boehringer Ingelheim on 2026-05-14.